Skip to main content
. 2017 Nov 15;8(65):108989–108999. doi: 10.18632/oncotarget.22480

Table 2. The risks of developing cancers in the stroke and control groups.

Characteristics Stroke Control Crude HR$
(95% CI)
Adjusted HRb
(95% CI)
N Cancer #PY Ratea N Cancer #PY Ratea
All 17161 1408 149263.46 9.43 68644 6763 665975.77 10.16 0.93 (0.88-0.98)* 0.79 (0.74-0.84)*
Age
 ≦40 688 22 6475.73 3.40 2752 46 28976.48 1.59 2.15 (1.29-3.57)* 1.79 (0.99-3.23)
 40-60 4116 276 38214.12 7.22 16464 1116 166239.69 6.71 1.08 (0.95-1.23) 0.90 (0.77-1.05)
 60-80 10002 975 86312.45 11.30 40008 5015 382530.71 13.11 0.86 (0.80-0.92)* 0.76 (0.71-0.82)*
 >80 2355 135 18261.16 7.39 9420 586 88228.89 6.64 1.08 (090-1.31) 0.73 (0.60-0.90)*
Gender
 Male 10039 946 85478.29 11.07 40156 4464 385779.52 11.57 0.96 (0.89-1.02) 0.81 (0.75-0.88)
 Female 7122 462 63785.17 7.24 28488 2299 280196.25 8.21 0.88 (0.80-0.98)* 0.74 (0.67-0.83)

#PY: person-years.

$HR: hazard ratio.

aRate: per 1000 person-years.

bAdjusted by age groups, gender and comorbidities.

*P-value<0.05.